AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Nov 16 2021
Headline Roundup
Pfizer to Allow Generic Drugmakers to Manufacture COVID-19 Antiviral Pill
Pharmaceutical company Pfizer announced Tuesday that it would allow generic drug companies around the world to produce its COVID-19 antiviral pill by granting a royalty-free license to Medicines Patent Pool, a U.N.-backed nonprofit.
Merck made a similar arrangement for its COVID-19 pill last month. Pfizer also formally asked the FDA to grant emergency use authorization for its pill.
The Daily Wire Associated Press New York Times (News)Oct 13 2020
Opinion
Vaccine development process is safe, claims of the contrary are baseless
All of our lives have been drastically impacted by the ongoing coronavirus pandemic — and we know all of us are eager to return to the way things were before the pandemic began. However, that simply won’t be possible without a safe, effective vaccine. Fortunately, due to the strength of American innovation and unprecedented public-private partnerships, a COVID-19 vaccine is on the horizon. We
Multiple Writers - Lean RightDec 27 2021
Headline Roundup
Paxlovid, Pfizer's COVID-19 Pill, May Mix Poorly With Other Common Medications
According to a report from NBC News, experts are warning that new antiviral pills to treat COVID-19 may not be safe for everyone.
Pfizer's Paxlovid pills were authorized by the Food and Drug Administration (FDA) last week for high-risk individuals, but there are concerns about how the medication will mix with treatments for other ailments. A pharmaceutical scientist told NBC News that
Newsmax (News) NBC News Digital The HillMay 26 2020
News
Stocks soar as New York Stock Exchange reopens floor to traders
Stock roared Tuesday coming off the holiday weekend, as the national shutdown continues to unwind, more drug companies chase coronavirus vaccines and the New York Stock Exchange reopened its floor to traders for the first time in two months.
The Dow Jones industrial average shot up nearly 600 points, about 2.3 percent, to push the blue-chip index past the 25,000 threshold. The Standard
Washington PostMay 26 2020
News
Stocks soar as NYSE trading floor reopens from coronavirus shutdown
U.S. equity markets surged to their best levels in months as states continued to reopen and traders returned to the New York Stock Exchange for the first time since shutting down on March 23 to slow the spread of COVID-19.
The Dow Jones Industrial Average rallied more than 600 points, or 2.45 percent, in the opening minutes of trading, while the S&P 500 and the Nasdaq Composite were
Fox News DigitalApr 15 2021
Analysis
Corporate America’s Empty Virtue Signaling
Critics of the Georgia elections law have gotten far out over their skis. The Washington Post fact-checker awarded Joe Biden “Four Pinocchios” for lying about the bill, then labeled him a “recidivist” when he kept repeating the lie. Senator Raphael Warnock admitted to Fox News that he had put his name to an email for a liberal nonprofit lying about a provision that was not in the final bill.
National Review (News)Mar 02 2021
Headline Roundup
Biden Says US Will Have Enough Vaccines for All Adults by End of May
President Joe Biden said Tuesday that the U.S. will have enough coronavirus vaccines for all adults by the end of May, two months sooner than his previous prediction. The revised estimate comes amid accelerated manufacturing efforts around Johnson & Johnson's newly approved single-shot vaccine, which Biden said rival pharmaceutical company Merck is helping produce under the Defense
New York Post (News) Al Jazeera Axios